Diapharma announces partnership with HemaCore
Posted: February 13, 2019
HemaCore was founded in 2010 as a biotech company focused on developing, manufacturing and implementing new technology for hemostasis – thrombodynamics.
Thrombodynamics® assay – an innovative coagulation test for risk assessment of blood coagulation disorders – bleedings and thrombosis.
HemaCore helps provide clear and reliable estimation of subjects coagulation state, thus giving an ability to prevent thrombotic or bleeding complications.
- Thrombodynamics® Analyzer (T2F)
- Thrombodynamics® Analyzer (T2T)
- Thrombodynamics® TDX Kit (TDX-10)
- Thrombodynamics® PLS Kit (PLS-10)